Literature DB >> 29170032

Negative Valence Life Events Promote Breast Cancer Development.

Avital Fischer1, Argyrios Ziogas1, Hoda Anton-Culver2.   

Abstract

BACKGROUND: The influence of stress on breast cancer risk remains unknown. The goal of the present study was to determine the effect of stress in the form of salient positive and negative valence life events (LEs) on primary invasive breast cancer risk. We hypothesized that salient negative LEs would increase breast cancer risk and salient positive LEs would attenuate this increased risk. PATIENTS AND METHODS: We used a case-control design with 664 cases identified through the Cancer Surveillance Program of Orange County and 203 population-based controls. Participants completed a risk factor questionnaire, which included a LE section. Fourteen salient LEs of positive or negative valence were used to quantify stress exposure. A baseline model was constructed, and odds ratios (ORs) were calculated using multivariate unconditional logistic regression.
RESULTS: Negative LEs were associated with increased breast cancer risk. The OR for ≥ 4 negative LEs showed a 2.81-fold increase in breast cancer risk (OR, 2.81; 95% confidence interval [CI], 1.47-5.36). A significant dose-response relationship between lifetime negative valence LEs and breast cancer risk was found. Previous personal illness increased breast cancer risk by 3.6-fold (OR, 3.60; 95% CI, 2.50-5.20). In contrast, abortion was associated with a 45% decrease in breast cancer risk (OR, 0.55; 95% CI, 0.34-0.89). Salient positive LEs did not have a significant effect on breast cancer risk. However, they seemed to buffer the adverse effect of salient negative LEs on breast cancer risk.
CONCLUSION: The findings from the present study support the role of salient negative LEs in promoting breast cancer development, with a possible buffering effect of salient positive LEs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Case-control study; Epidemiology; LEs; Stress

Mesh:

Year:  2017        PMID: 29170032      PMCID: PMC6541225          DOI: 10.1016/j.clbc.2017.10.017

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  32 in total

Review 1.  Stress-induced immunomodulation: Implications for tumorigenesis.

Authors:  Eric V Yang; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2003-02       Impact factor: 7.217

Review 2.  Psycho-oncology and cancer: linking psychosocial factors with cancer development.

Authors:  B Garssen
Journal:  Ann Oncol       Date:  2002       Impact factor: 32.976

Review 3.  The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.

Authors:  Karolien De Bosscher; Wim Vanden Berghe; Guy Haegeman
Journal:  Endocr Rev       Date:  2003-08       Impact factor: 19.871

4.  Scaling of life events.

Authors:  E S Paykel; B A Prusoff; E H Uhlenhuth
Journal:  Arch Gen Psychiatry       Date:  1971-10

5.  Hypertension, diuretics and breast cancer risk.

Authors:  J A Largent; A J McEligot; A Ziogas; C Reid; J Hess; N Leighton; D Peel; H Anton-Culver
Journal:  J Hum Hypertens       Date:  2006-08-03       Impact factor: 3.012

6.  Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2.

Authors:  S Sengupta; B Wasylyk
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

7.  Characterizing changes in student empathy throughout medical school.

Authors:  Daniel C R Chen; Daniel S Kirshenbaum; Jun Yan; Elaine Kirshenbaum; Robert H Aseltine
Journal:  Med Teach       Date:  2012       Impact factor: 3.650

8.  Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer.

Authors:  H Anton-Culver; P F Cohen; M E Gildea; A Ziogas
Journal:  Eur J Cancer       Date:  2000-06       Impact factor: 9.162

Review 9.  What causes breast cancer? A systematic review of causal attributions among breast cancer survivors and how these compare to expert-endorsed risk factors.

Authors:  Jo Anne Dumalaon-Canaria; Amanda D Hutchinson; Ivanka Prichard; Carlene Wilson
Journal:  Cancer Causes Control       Date:  2014-04-27       Impact factor: 2.506

Review 10.  Stress, depression, the immune system, and cancer.

Authors:  Edna Maria Vissoci Reiche; Sandra Odebrecht Vargas Nunes; Helena Kaminami Morimoto
Journal:  Lancet Oncol       Date:  2004-10       Impact factor: 41.316

View more
  3 in total

1.  Latent Class Models of Early-life Trauma and Incident Breast Cancer.

Authors:  Jennifer M P Woo; Amanda Simanek; Katie M O'Brien; Christine Parks; Symielle Gaston; Paul L Auer; Rebecca Headley Konkel; Chandra L Jackson; Helen C S Meier; Dale P Sandler
Journal:  Epidemiology       Date:  2022-05-16       Impact factor: 4.860

2.  Stressful Life Events and Distress in Breast Cancer: A 5-Years Follow-Up.

Authors:  Cristian Ochoa-Arnedo; Clàudia Prats; Noemie Travier; Laia Marques-Feixa; Aida Flix-Valle; María Lleras de Frutos; Esperanza Domingo-Gil; Joan Carles Medina; Maria Serra-Blasco
Journal:  Int J Clin Health Psychol       Date:  2022-04-01

3.  Psychological suppressive profile and autoantibodies variability in women living with breast cancer: A prospective cross-sectional study.

Authors:  Tania Romo-González; Antonia Barranca-Enríquez; Rosalba León-Díaz; Enrique Del Callejo-Canal; Gabriel Gutiérrez-Ospina; Angela María Jimenez Urrego; Cristina Bolaños; Alejandro Botero Carvajal
Journal:  Heliyon       Date:  2022-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.